SCHEMBL7521571

SCHEMBL7521571

CC(C)(C)c1cc(-n2nc3ccccc3n2)c(O)c(C(C)(c2ccc(OCCO)cc2)c2ccc(OCCO)cc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
CYP3A4 P08684 1/20 0.38
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
PIN1 Q13526 1/20 0.36
TP53 P04637 2/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 2/20 0.35
ACSS2 Q9NR19 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
RECQL P46063 1/20 0.34
LMNA P02545 2/20 0.34
MITF O75030 1/20 0.34
HPGD P15428 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NR1H2 P55055 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6862331 0.92 SMN1; SMN2 (0.38) SMN1; SMN2CYP3A4NPC1RAB9APIN1
SCHEMBL7655370 0.91 NPC1 (0.36) SMN1; SMN2NPC1RAB9APIN1TP53
SCHEMBL7516817 0.86 HTT (0.45) SMN1; SMN2CYP3A4NPC1RAB9ATP53
SCHEMBL7521872 0.85 HPGD (0.46) SMN1; SMN2NPC1RAB9ATP53MAPT
SCHEMBL7519989 0.83 NPC1 (0.45) SMN1; SMN2CYP3A4NPC1RAB9AMAPT
SCHEMBL6861261 0.82 NPC1 (0.36) SMN1; SMN2NPC1RAB9APIN1TP53
SCHEMBL11136454 0.81 NPC1 (0.41) SMN1; SMN2NPC1RAB9AMAPTPOLB
SCHEMBL29708 0.78 NPC1 (0.49) SMN1; SMN2CYP3A4NPC1RAB9APOLB
SCHEMBL29350736 0.78 NPC1 (0.49) SMN1; SMN2CYP3A4NPC1RAB9APOLB
SCHEMBL6860452 0.78 HPGD (0.47) SMN1; SMN2NPC1RAB9ATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489383-B1 SUCH AS 2-(2-HYDROXY-3-(1,1-DI(4-2-(BROMOETHOXY)PHENYL) ETHYL)-5-TERT-BUTYLPHENYL)-2H-BENZOTRIAZOLE FOR USE AS STOVING LACQUER, FINISHING ENAMEL FOR AUTOMOBILES CIBA SPECIALTY CHEMICALS CORPORATION 2002-12-03 US disclosed
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith WOOD MERVIN G (US) 2002-11-14 US disclosed
US-6392056-B1 FOR THERMOPLASTIC RESINS CIBA SPECIALTY CHEMICAL CORPORATION 2002-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith SUV39H1, SUV39H2, PAH SMN1; SMN2 3397/4885CYP3A4 72/4885NPC1 3986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.